Surgical treatment of double aortic arch in infants

Chenhan Wang1, Bingjie Chen1, Jingnan Chen1

  • 1Department of Cardiothoracic Surgery, The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University (Hunan Children's Hospital), Changsha, Hunan, China.

Frontiers in Pediatrics
|September 2, 2025
PubMed

Insights

Surgical repair of double aortic arch (DAA) is safe and effective for infants and children. Outcomes are favorable, even with associated heart defects, showing good symptom relief.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Congenital Heart Disease

Background:

  • Double aortic arch (DAA) is a rare congenital vascular anomaly causing tracheal and esophageal compression.
  • Symptoms include respiratory and gastrointestinal issues, necessitating timely diagnosis and surgical intervention.
  • Limited data exists on surgical outcomes and long-term follow-up for DAA repair.

Purpose of the Study:

  • To retrospectively analyze surgical outcomes and perioperative management of DAA.
  • To elucidate optimal diagnostic and therapeutic approaches for DAA.
  • To compare outcomes between isolated DAA and DAA with intracardiac anomalies.

Main Methods:

  • Retrospective cohort study of patients undergoing DAA repair (August 2015-May 2024).
  • Patients stratified into isolated DAA or DAA with associated intracardiac anomalies groups.
  • Demographic, operative, and outcome variables were compared between groups.

Main Results:

  • 10 patients underwent DAA repair; 6 isolated DAA, 4 with intracardiac anomalies.
  • No significant differences in symptom onset, anatomic subtypes, or clinical manifestations between groups.
  • Shorter operative time for isolated DAA (104.8 min vs. 233.3 min). No significant intergroup differences in perioperative variables or complication rates.
  • Near-complete symptom resolution in 9/10 survivors at mean 12.7-month follow-up.

Conclusions:

  • Surgical repair of DAA is safe and effective in infants and children.
  • Favorable short-to-midterm clinical outcomes are achieved regardless of concomitant intracardiac anomalies.
  • DAA repair leads to significant symptom resolution and acceptable safety profiles.
Abstract